{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Of all medicines, the little white pill known as aspirin has long been the most widely used and the cheapest, as well as arguably the most effective drug in its field. But such claims brought little cheer to Bayer, the original manufacturer and synthesizer -- 100 years ago tomorrow -- of a simple chemical compound that was turned into one of the world's best-known brands. Outgunned by newer painkillers and underpriced by generic and private labels, Bayer aspirin's market share in the United States plummeted from 20 percent in the late 1960's to a low of 4.5 percent in 1994.", "headline": {"main": "A Pill's Heart Benefits Help the Bottom Line", "kicker": "2d Chance For Aspirin Is Also One For Bayer"}, "abstract": "Bayer Aspirin is seen making modest comeback, after being outgunned by newer painkillers and underpriced by generic and private labels; Bayer aspirin's market share in United States plummeted from 20 percent in late 1960's to low of 4.5 percent in 1994; two things are at heart at Bayer aspirin's recovery from sick bed: American rights to Bayer name and trade mark were returned--after hiatus of 78 years--to Bayer AG, Germany company committed to promoting its namesake; at same time, American marketing team, taking advantage of scientific evidence that aspirin is the only headache medicine that also helps prevent blood clots and heart disease, comes up with breakthrough selling strategy; they advertise Bayer for 'powerful pain relief, and so much more'; chronology of Bayer aspirin's history; photos; chart (M)", "print_page": "35", "word_count": 1520, "_id": "4fd1d5348eb7c8105d712c72", "snippet": "Of all medicines, the little white pill known as aspirin has long been the most widely used and the cheapest, as well as arguably the most effective drug in its field. But such claims brought little cheer to Bayer, the original manufacturer and...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1997/08/09/business/a-pill-s-heart-benefits-help-the-bottom-line.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "BAYER AG"}, {"name": "subject", "value": "HEART"}, {"name": "subject", "value": "ADVERTISING"}, {"name": "subject", "value": "MARKETING AND MERCHANDISING"}, {"name": "subject", "value": "PAIN-RELIEVING DRUGS"}, {"name": "subject", "value": "ASPIRIN"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Milt", "lastname": "FREUDENHEIM"}], "original": "By MILT FREUDENHEIM"}, "document_type": "article", "pub_date": "1997-08-09T00:00:00Z", "section_name": "Health; Business"}], "meta": {"hits": 1, "offset": 0, "time": 55}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}